Trial intelligence / Profile preview

Randomized open-label cross-over study of pramipexole in severe sleep bruxism

2009-010282-23Phase 2Completed

Sponsor
Tandvården Sahlgrenska Universitetssjukhuset
Start
Sep 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of pramipexole in sleep bruxism (2 arms), sponsored by Tandvården Sahlgrenska Universitetssjukhuset. Primary endpoints: Bruxism episodes per hour and Treatment responder frequency. Started Sep 2010; status: completed.

02

Drugs

pramipexole
03

Conditions

sleep bruxism

Beyond the preview

Go deeper on 2009-010282-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-010282-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call